Embargoed until 10:15 AM PST, February 11, 2026 In a groundbreaking development within obstetric medicine, a new observational study presented...
risk
Korean medical AI company Lunit is advancing its U.S. expansion by submitting its breast cancer risk prediction solution, Lunit INSIGHT...
A landmark clinical trial co-led by Hospital for Special Surgery (HSS) has found that blocking inflammation with the drug certolizumab...
GAINESVILLE, Fla. — The life of billions of people inhabiting Earth is owed to a temporary organ that supported and...
Transmission electron micrograph of copper oxide nanoparticles. (A) Copper oxide nanoparticles synthesised by aqueous precipitation show a spherical shape, with...
Prioritizing sensitivity Importantly, the latest study validates the screening tool in a new set of patients. This is essential to...